Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients

Clinical trial NCT03733691 · TERMINATED

Trial details

NCT number: NCT03733691
Sponsor: Oncotherapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Newly Diagnosed Multiple Myeloma

Start date: 2019-03-01
Primary completion: 2023-10-19
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.